Corbus Pharmaceuticals Inc. (CRBP) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Corbus Pharmaceuticals I...

    NASDAQ: CRBP · Real-Time Price · USD
    9.88
    0.02 (0.20%)
    At close: Sep 08, 2025, 11:57 AM

    Corbus Pharmaceuticals Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 n/a n/a n/a 881.71K
    Cost of Revenue
    		 600K 31.17M 1.49M 1.64M
    Gross Profit
    		 -600K -31.17M -1.49M -757.53K
    Operating Income
    		 -48.72M -45.08M -34.84M -55.99M
    Interest Income
    		 6.31M n/a n/a 1.83K
    Pretax Income
    		 -40.21M -44.6M -42.35M -45.64M
    Net Income
    		 -40.21M -44.6M -55.83M -45.55M
    Selling & General & Admin
    		 16.5M 13.27M 18.7M 20.43M
    Research & Development
    		 32.22M 31.17M 16.14M 36.45M
    Other Expenses
    		 -600K -30.53M -1.49M -1.64M
    Operating Expenses
    		 48.12M 13.91M 33.35M 55.23M
    Interest Expense
    		 1.87M 2.92M 2.13M 1.83M
    Selling & Marketing Expenses
    		 n/a -641K n/a n/a
    Cost & Expenses
    		 48.72M 45.08M 34.84M 56.87M
    Income Tax Expense
    		 n/a n/a n/a -87.84K
    Shares Outstanding (Basic)
    		 10.91M 4.33M 4.17M 4.1M
    Shares Outstanding (Diluted)
    		 10.91M 4.33M 4.17M 4.1M
    EPS (Basic)
    		 -3.68 -10.31 -10.15 -11.11
    EPS (Diluted)
    		 -3.68 -10.31 -10.15 -11.11
    EBITDA
    		 -37.74M -44.44M -38.73M -54.97M
    EBIT
    		 -38.34M -45.08M -40.21M -55.99M
    Depreciation & Amortization
    		 600K 641K 1.49M 1.64M

    Add to Watchlist